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Abstract
Introduction: Post-cardiac arrest syndrome (PCAS) often leads to multiple organ dysfunction syndrome (MODS)
with a poor prognosis. Endothelial and leukocyte activation after whole-body ischemia/reperfusion following
resuscitation from cardiac arrest is a critical step in endothelial injury and related organ damage. Angiogenic
factors, including vascular endothelial growth factor (VEGF) and angiopoietin (Ang), and their receptors play crucial
roles in endothelial growth, survival signals, pathological angiogenesis and microvascular permeability. The aim of
this study was to confirm the efficacy of angiogenic factors and their soluble receptors in predicting organ
dysfunction and mortality in patients with PCAS.
Methods: A total of 52 resuscitated patients were divided into two subgroups: 23 survivors and 29 non-survivors.
The serum levels of VEGF, soluble VEGF receptor (sVEGFR)1, sVEGFR2, Ang1, Ang2 and soluble Tie2 (sTie2) were
measured at the time of admission (Day 1) and on Day 3 and Day 5. The ratio of Ang2 to Ang1 (Ang2/Ang1) was
also calculated. This study compared the levels of angiogenic factors and their soluble receptors between survivors
and non-survivors, and evaluated the predictive value of these factors for organ dysfunction and 28-day mortality.
Results: The non-survivors demonstrated more severe degrees of organ dysfunction and a higher prevalence of
MODS. Non-survivors showed significant increases in the Ang2 levels and the Ang2/Ang1 ratios compared to
survivors. A stepwise logistic regression analysis demonstrated that the Ang2 levels or the Ang2/Ang1 ratios on
Day 1 independently predicted the 28-day mortality. The receiver operating characteristic curves of the Ang2 levels,
and the Ang2/Ang1 ratios on Day 1 were good predictors of 28-day mortality. The Ang2 levels also independently
predicted increases in the Sequential Organ Failure Assessment (SOFA) scores.
Conclusions: We observed a marked imbalance between Ang1 and Ang2 in favor of Ang2 in PCAS patients, and
the effect was more prominent in non-survivors. Angiogenic factors and their soluble receptors, particularly Ang2
and Ang2/Ang1, are considered to be valuable predictive biomarkers in the development of organ dysfunction and
poor outcomes in PCAS patients.
Introduction
There have been progressive improvements in the man-
agement of cardiac arrest, including modern cardiopul-
monary resuscitation and emergency cardiovascular care.
Nevertheless, the prognosis of successfully resuscitated
patients remains poor, and life-threatening disturbances
known as “post-resuscitation disease” or “post-cardiac
arrest syndrome (PCAS)” can lead to multiple organ dys-
function syndrome (MODS) [1]. Endothelial and leuko-
cyte activation after whole-body ischemia/reperfusion
following resuscitation from cardiac arrest is a critical
step in endothelial injury and related organ damage [2].
Prolonged ischemia results in severe tissue and organ
damage, reperfusion-induced injury; defined as tissue
damage directly related to revascularization; may be even
more harmful [3,4].
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Vascular endothelial growth factor (VEGF) plays crucial
roles in angiogenesis and microvascular permeability [5].
VEGF signaling in endothelial cells releases cytokines and
chemokines, and induces the expression of procoagulant
and cell adhesion molecules. VEGF primarily binds to two
transmembrane receptors, VEGF receptor (VEGFR)-1 and
VEGFR2. VEGFR2 is selectively expressed in the endothe-
lium and mainly mediates endothelial growth, survival sig-
nals and pathological angiogenesis. In contrast, VEGFR1 is
present on both endothelial cells and monocytes, and
VEGFR1-mediated signaling plays important roles by
increasing the vascular permeability under pathological
conditions, such as ischemia and inflammation.
The angiopoietin (Ang)-Tie2 ligand-receptor system is
restricted to the regulation of the endothelium and is
involved in multiple MODS-related pathways [6]. The
Ang-Tie2 system not only regulates angiogenesis, but
also controls endothelial inflammation, along with VEGF
and its receptor system [7,8]. Ang1 stabilizes endothelial
cells, inhibits vascular leakage, and suppresses inflamma-
tory and coagulation-related gene expression through
Tie2 activation [8-10]. Ang2 antagonizes the binding of
Ang1 to Tie2. Therefore, Ang2 is thought to act as a
proinflammatory mediator by increasing fluid leakage
through the endothelial vasculature [11]. Several studies
have demonstrated that the ratio of Ang1 to Ang2 better
describes the state of activation of the endothelium,
because Ang1 and Ang2 exhibit agonist-antagonist
effects on the endothelium [12,13].
Many studies have demonstrated a relationship between
the pathophysiology of sepsis and the activities of angio-
genic factors, including VEGF, angiopoietins and corre-
sponding receptors. We have observed a relationship
between angiogenic factors, their receptors and dissemi-
nated intravascular coagulation (DIC) associated with sep-
sis [14]. In addition, we have demonstrated the presence
of a pathophysiological relationship between angiogenic
factors and their soluble receptors and organ dysfunction
in patients with DIC associated with severe trauma [15].
However, no previous reports have documented data
regarding angiogenic factors and their soluble receptors in
patients with PCAS. The aim of this study were to test the
hypothesis that angiogenic factors and their soluble recep-
tors play pivotal roles in the development of organ dys-
function related to PCAS, thus leading to a poor outcome,
and to confirm the efficacy of these factors as prognostic




This study was performed from May 2001 until April
2008. Approval for this study was obtained from the insti-
tutional review board, the Ethics Committee of Hokkaido
University School of Medicine. Informed consent for this
study was obtained from the patients’ next of kin. Cardiac
arrest was defined as the absence of a palpable pulse of the
common carotid artery confirmed by an emergency medi-
cal service worker. Patients were excluded if they were
younger than 18 years of age or had a terminal illness or
history of trauma-induced arrest. Cardiopulmonary resus-
citation was performed in accordance with the Guidelines
2000 for Cardiopulmonary Resuscitation and Emergency
Cardiovascular Care [16]. A total of 52 patients resusci-
tated after out-of hospital cardiac arrest from May 2001 to
April 2008 were enrolled in the study. The patients were
subdivided into survivors and non-survivors according to
their 28-day mortality. All patients were also divided into
MODS and non-MODS groups. Fifteen healthy adult
volunteers served as the control subjects.
Definitions
The patients’ severity of illness was evaluated according
to the Acute Physiology and Chronic Health Evaluation
(APACHE) II score determined after the first 24 hours of
admission [17]. Organ dysfunction was assessed accord-
ing to the Sequential Organ Failure Assessment (SOFA)
score [18]. Multiple organ dysfunction syndrome
(MODS) was defined as a SOFA score > 12 [18]. Overt
DIC scores based on the International Society on Throm-
bosis and Haemostasis (ISTH) criteria were calculated
[19]. A diagnosis based on the ISTH criteria was estab-
lished when the total score was > 5. We defined the max-
imum score (max) as the highest score observed during
the study period. The main outcome measure was 28-day
mortality.
Study protocol and measurement methods
Blood samples were collected using an arterial catheter
within 24 hours of arrival at the emergency department
(Day 1), and on Days 3 and 5. The blood samples were
immediately placed into individual tubes and centrifuged
at 3,000 rpm, for five minutes at 4°C. The serum and/or
plasma were stored at -80°C until used for the assay.
The following variables were measured in duplicate:
VEGF (Human VEGF, Quantikene; R&D Systems, Inc.,
Minneapolis, MN, USA); soluble VEGF receptor
(sVEGFR)1 (Human sVEGF R1/Flt-1, Quantikene; R&D
Systems, Inc.); sVEGFR2 (Human sVEGF R2/KDR/Flk-1,
Quantikene; R&D Systems, Inc.); Ang1 (Human Angio-
poietin-1, Quantikene; R&D Systems, Inc.); Ang2 (Human
Angiopoietin-2, Quantikene; R&D Systems, Inc.); and
soluble Tie2 receptor (sTie2) (Human Tie-2, Quantikene;
R&D Systems, Inc.).
Statistical analysis
The statistical analyses and calculations were performed
with the SPSS 19.0 software package (SPSS, Inc.,
Wada et al. Critical Care 2012, 16:R171
http://ccforum.com/content/16/5/R171
Page 2 of 9
Chicago, IL, USA). Differences between groups were
analyzed using a two-sided nonparametric Mann-
Whitney U test, and categorical variables were com-
pared using Pearson’s chi-square test or Fisher’s exact
test when required. The Shapiro-Wilk test was used for
statistical testing of normality. Logarithmic transforma-
tions were made for all variables when needed. A step-
wise logistic regression analysis was used to assess the
relationship between the 28-day mortality and age, gen-
der, the APACHE II score ISTH DIC score on Day 1
and the levels of VEGF, sVEGFR1, sVEGFR2, Ang1,
Ang2, Ang2/Ang1, sTie2, the logarithmic transformation
form of Ang2 (Ang2(log10)), and Ang2/Ang1(log10) on
Day 1. A multiple regression analysis was also per-
formed to assess the relationship between the SOFA
score max and the same variables. Variables found to be
statistically significant at a 10% level in the univariate
analysis were included in the multivariate model. Recei-
ver operating characteristic (ROC) curves were con-
structed for the outcome (death), based on the levels of
Ang2, the Ang2/Ang1 ratios on Day 1. The areas under
the ROC curves (AUC) with standard error (SE) were
examined using a significance test for AUC. The optimal
cutoff value was determined using the Youden index. A
P-value < 0.05 was considered to be statistically signifi-




The causes of cardiac arrest are shown in Table 1.
There were no significant differences between the two
groups. Table 2 presents the characteristics of the
patients in the two groups. There was a significantly
higher proportion of females among the non-survivors.
A witnessed arrest, bystander cardio-pulmonary resusci-
tation (CPR) and the time intervals did not significantly
differ between survivors and non-survivors. There were
significant differences in the defibrillation attempt and
the doses of adrenalin. The non-survivors demonstrated
higher ISTH DIC score max, APACHE II scores, more
severe degrees of organ dysfunction (SOFA score max)
and a higher prevalence of MODS.
Serial changes in values of angiogenic factors and their
soluble receptors
Serial changes in the circulating levels of VEGF,
sVEGFR1 and sVEGFR2 are presented in Figure 1. The
resuscitated patients showed significantly higher levels
of sVEGFR1 and lower levels of VEGF and sVEGFR2 in
comparison to the controls. The levels of VEGF,
sVEGFR1 and sVEGFR2 did not show any significant
differences between the survivors and the non-survivors
during the entire study period. Figure 2 presents the
levels of Ang1, Ang2, sTie2 and the Ang2/Ang1 ratio.
Although the Ang1 levels in the resuscitated patients
were significantly lower than those in the control sub-
jects, no statistically significant differences were
observed between the survivors and the non-survivors.
On the contrary, the Ang2 levels in the non-survivors
were significantly higher than those in the control sub-
jects and the survivors throughout the study period.
Therefore, the Ang2/Ang1 ratios significantly increased
in the non-survivors. In addition, the sTie2 levels mea-
sured on Day 5 were higher in the non-survivors than
in the survivors.
Relationships between angiogenic factors, their soluble
receptors and mortality
A linear regression analysis detected a strong association
between Ang2(log10) and the APACHE II scores (r2 =
.521, P < .001; Figure 3). Table 3 shows that the Ang2
level or the Ang2/Ang1 ratio was identical as a strong,
independent prognostic factor for 28-day mortality in
this cohort of PCAS patients. APACHE II score and the
ISTH overt DIC score on Day 1 also predicted 28-day
mortality in PCAS patients. The ROC curves of the
Ang2 levels and the Ang2/Ang1 on Day 1 used to pre-
dict 28-day mortality and the AUC (SE), 95% confidence
interval (CI), optimal cutoff point value, sensitivity and
specificity of the ROC curves are shown in Figure 4.
Both values were found to be good predictors of 28-day
mortality.
Relationships between angiogenic factors, their soluble
receptors and organ dysfunction
Figure 5 shows the serial changes in the circulating
levels of Ang1, Ang2 and the Ang2/Ang1 ratios in the
non-MODS and MODS groups. The Ang2 levels in the
non-MODS group were identical to those in the control
subjects; however, those in the MODS group were sig-
nificantly higher than those in the control subjects and
the non-MODS group during the study period. There-
fore, the Ang2/Ang1 ratios significantly increased in the
MODS group during the study period. A multiple linear
regression analysis suggested that Ang2(log10) was an
independent best predictor of changes in SOFA(log10)
(Table 4).
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Discussion
The present study found that Ang2 plays a pivotal role
in the development of organ dysfunction associated
PCAS, thus leading to a poor outcome. Moreover, the
Ang2 level or the Ang2/Ang1 ratio can predict the
development of organ dysfunction and mortality in
patients with PCAS.
Lower VEGF levels are also associated with organ dys-
function and a poor outcome in patients with sepsis
[20,21]. We have demonstrated that patients with DIC
associated with severe trauma show lower levels of
VEGF [15]. On the other hand, several studies have
reported that the plasma VEGF levels in patients with
septic shock are higher than those in patients without
shock, and that the VEGF concentration at the time of
admission correlates with the severity of disease [22,23].
In addition, sVEGFR1, which is generated by alternative
splicing of VEGFR1 mRNA and functions as a decoy
molecule, competing with VEGFR1 for binding to
VEGF, is correlated with morbidity and mortality and is
a potent marker of disease severity in septic or critically
ill patients [15,23-25]. Meanwhile, previous reports have
suggested that VEGFR1 is involved in the migration of
monocytes/macrophages, and that elevation of sVEGFR1
leads to an anti-inflammatory state [24,26]. Therefore,
the significance of the levels of VEGF and sVEGFR1 in
patients with critical illnesses, such as severe sepsis, sep-
tic shock and severe trauma remains controversial
[12,15,24]. The present study found that PCAS patients
have lower levels of VEGF and higher levels of sVEGFR1
than control subjects; however, the levels of VEGF and
sVEGFR1 are not significantly different between survi-
vors and non-survivors. These results suggest that the
VEGF/VEGFR signaling pathways may play minor roles
in the pathophysiology of PCAS. Similarly, in this study,
the sVEGFR2 levels were not significantly different
between survivors and non-survivors in PCAS patients.
sVEGFR2 may have regulatory consequences with
respect to VEGF-mediated angiogenesis. However, its
precise role has not yet been clarified [27]. These results
also indicate that sVEGFR2 may not play a major role
in PCAS.
PCAS is often compared to “sepsis-like syndrome”,
because it is characterized by high levels of circulating
cytokines and adhesion molecules and the dysregulated
leukocyte production of cytokines [3,4]. Previous studies
have shown lower Ang1 and higher Ang2 levels to be
associated with poorer outcomes in patients with sepsis
or critical illness [9,20,28,29]. Ang1 exhibits anti-inflam-
matory properties and protects against vascular leakage,
while Ang2 promotes inflammation and increases vascu-
lar permeability leading to the development of acute
respiratory distress syndrome (ARDS) [8,9,30,31]. More-
over, positive relationships between Ang2 and inflamma-
tory cytokines, such as tumor-necrosis factor (TNF)-
alpha and interleukin (IL)-6 are observed in severe sep-
sis [28]. Therefore, an elevation in the Ang2 level and a
decrease in the Ang1 level may reflect a pro-inflamma-
tory state that is best summarized by the ratio of Ang1
to Ang2 [12,13]. The current study and previous studies
Table 2 The baseline clinical characteristics of survivors and non-survivors of PCAS patients
Survivors (n = 23) Non-survivors (n = 29) P value
Age (years) 62 ± 5 66 ± 4 0.423
Gender (male/female) 20/3 13/16 0.002
Witnessed arrest (yes/no) 12/11 14/15 0.780





1 6.5 ± 0.6 6.2 ± 0.4 0.874
2 13.9 ± 1.3 13.2 ± 1.5 0.483
3 33.4 ± 2.1 32.5 ± 1.5 0.919
4 35.3 ± 2.9 34.8 ± 2.3 0.846
Defibrillation (yes/no) 9/14 3/26 0.014
Adrenalin (mg) 1.4 ± 0.3 2.6 ± 0.4 0.044
APACHE II score 26.4 ± 1.4 34.3 ± 1.1 < 0.001
SOFA score max 5.1 ± 0.5 8.7 ± 0.7 0.001
MODS (yes/no) 1/22 9/20 0.015
ISTH DIC score max 1.7 ± 0.3 3.0 ± 0.3 0.006
*1, interval between the receipt of the emergency call and arrival of the vehicle; 2, interval between the arrival of the vehicle and the arrival at the ED; 3, interval
between the receipt of the emergency call and the arrival at the ED; 4, total CPR time; APACHE, Acute Physiology and Chronic Health Evaluation; CPR, cardio-
pulmonary resuscitation; DIC, disseminated intravascular coagulation; ISTH, International Society on Thrombosis and Haemostasis; max, maximum score; MODS,
multiple organ dysfunction syndrome; PEA, pulseless electrical activity; SOFA, Sequential Organ Failure Assessment; Vf, ventricular fibrillation
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suggest that reperfusion-induced endothelial injury is
reflected in higher Ang2 levels, as well as imbalances of
Ang1 and Ang2 (high Ang2/Ang1 ratios) that are asso-
ciated with systemic inflammatory responses leading to
organ dysfunction and death in PCAS patients. The
administration of Ang1 protects the vasculature from
leakage, thereby countering the potentially lethal actions
of VEGF and inflammatory agents in animal experi-
ments [32]. Correcting imbalances between Ang1 and
Ang2 with administration of Ang1 or inhibition of Ang2
Figure 1 The levels of VEGF, sVEGFR1 and sVEGFR2. White bars,
control subjects; gray bars, survivors; black bars, non-survivors.
Figure 2 The levels of Ang1, Ang2, sTies2 and the Ang2/Ang1
ratios. White bars, control subjects; gray bars, survivors; black bars,
non-survivors.
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may, therefore, represent new therapeutic strategies for
treating severe inflammatory illnesses such as PCAS.
PCAS is also similar to “sepsis-like syndrome” with
respect to the coagulofibrinolytic abnormalities asso-
ciated with cardiopulmonary resuscitation (CPR) and
the return of spontaneous circulation. Whole-body
ischemia and reperfusion- induced endothelial injury,
contribute to thrombotic occlusion of the vessels follow-
ing the activation of coagulation and the impairment of
fibrinolysis [1,33-35]. These changes lead to DIC in
patients resuscitated from cardiac arrest [34,35]. The
current study demonstrates both the Ang2 levels and
the ISTH overt DIC scores to be independent predictors
of mortality in PCAS patients. We have demonstrated
that Ang2 is one of the pathophysiological factors med-
iating organ dysfunction in patients with DIC associated
with sepsis and severe trauma [14,15]. These results sug-
gest that no matter the causes, Ang2 may play a crucial
role in the development of organ dysfunction, thus lead-
ing to a poor outcome. In addition, the results of these
studies support our hypothesis that all insults (trauma/
surgery, infection and ischemia/reperfusion) may bring
out similar nonspecific body responses, such as inflam-
mation, neuroendocrine discharge, coagulation and fibri-
nolysis to maintain body homeostasis [36].
The current study has several limitations. The present
data are not consecutive; however, we believe that there
was no bias in the enrollment because we included all
patients whose data were collected by the data collector
in the present study. Table 2 shows that females had
significantly higher mortality. This result is probably due
to a type I error related to the small number of patients.
The causes of cardiac arrest in the study are diverse,
including acute coronary syndrome, asphyxia, subarach-
noid hemorrhage and so on. However, we believe that
the injuries caused by hypoxia/ischemia and subsequent
reperfusion overwhelm any injuries associated with the
specific cause of cardiac arrest. Introduction of routine
therapeutic hypothermia, which may interfere with coa-
gulation, was not performed because this study was
completed before the publication of studies showing the
Figure 3 Scatter plots showing the correlations between Ang2
(log10) and the Acute Physiology and Chronic Health
Evaluation (APACHE) II score in 52 resuscitated patients
(survivors (n = 23), non-survivors (n = 29)). r2 = .521, P < .001.
Table 3 The results of the univariate and multivariate logistic regression analysis for predicting 28-day mortality in
PCAS patients
Univariate Multivariate
Variables OR 95% CI P value OR 95% CI P value
Age (years) 1.010 0.983-1.038 0.455
Gender (m/f) 8.205 1.989-33.847 0.004 21.5 2.769-166.4 0.003
ISTH DIC score 1.630 1.093-2.431 0.017 2.016 1.131-3.753 0.018
VEGF 1.000 0.995-1.004 0.862
sVEGFR1 1.000 0.999-1.000 0.166
sVEGFR2 1.000 1.000-1.001 0.507
Ang1 1.000 1.000-1.000 0.386
Ang2/Ang1a 1.401 1.028-1.910 0.033 1.381 1.044-1.827 0.024
Ang2/Ang1(log10)a 7.488 1.870-29.987 0.004 15.769 2.281-109.01 0.005
Ang2ab 1.000 1.000-1.001 0.007 1.000 1.000-1.001 0.018
Ang2(log10)ab 56.524 4.803-665.225 0.001 90.484 3.383-2420.48 0.007
sTie2 1.055 0.929-1.199 0.410
APACHE IIab 1.223 1.085-1.378 0.001 1.206 1.044-1.394 0.011
Ang2(log10), P = 0.414; APACHE II, P = 0.151). CI, confidence interval; OR, odds ratio.
a Different models were established, incorporating either the Ang2/Ang1, Ang2/Ang1(log10), Ang2, Ang2(log10), and APACHE II score, respectively. The models
were tested separately.
b ISTH DIC did not remain significant in these models, (Ang2, P = 0.363)
Wada et al. Critical Care 2012, 16:R171
http://ccforum.com/content/16/5/R171
Page 6 of 9
benefits of therapeutic hypothermia in comatose survi-
vors [37].
Conclusions
In the present study, non-survivors with PCAS showed
significant increases in the Ang2 levels and Ang2/Ang1
ratios in comparison to survivors throughout the entire
study period. The Ang2 level or the Ang2/Ang1 ratio
and the ISTH overt DIC scores on Day 1 were found to
be strong predictors of 28-day mortality in PCAS
patients. Ang2 also independently predicted increases in
the SOFA scores. These results suggest that Ang2 or
Ang2/Ang1 may be an informative predictor of the
development of organ dysfunction and mortality in
patients with PCAS. Additionally, angiogenic factors, in
particular Ang2, may play important roles in the devel-
opment of organ dysfunction, leading to death in PCAS
patients. Correcting imbalances between Ang1 and
Ang2 with the administration of Ang1 or the inhibition
of Ang2 may, therefore, represent new therapeutic stra-
tegies for treating severe inflammatory illnesses, such as
PCAS.
Key messages
• The VEGF/VEGFR signaling pathways may play a
minor role in the pathophysiology of PCAS.
• The Ang2 level, the Ang2/Ang1 ratio and the
ISTH DIC score can predict 28-day mortality in
PCAS patients.
• Ang2 is also an independent predictor of increas-
ing SOFA scores.
• Angiogenic factors, in particular Ang2, may play
important roles in the development of organ dys-
function, leading to death in PCAS patients.
Figure 4 The receiver operating characteristic (ROC) curve
analysis for the outcome (death).
Figure 5 The levels of Ang1, Ang2 and the Ang2/Ang1 ratios
in the serum of PCAS patients. White bars, control subjects; gray
bars, non-MODS; black bars, MODS.
Table 4 The results of a multiple regression analysis
using the stepwise method for predicting the SOFA score
max in PCAS patients
B SE ß P value 95% CI
SOFA(log10)
Ang2(log10) 0.338 0.087 0 .489 < 0.001 0.163-0.513
R2 = 0.224, ANOVA P < 0.001
ß, standard partial regression coefficient; ANOVA, analysis of variance. B,
partial regression coefficient; CI, confidence interval; R2, coefficient of
determinant; SE, standard error. Potential predictive variables included
logarithmic transformation of age, APACHE II score, and levels of all
angiogenic factors and their receptors on Day 1.
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